§325-116  Reports.  The department, on or before January 1 of each year, shall submit a report to the sterile needle exchange program oversight committee.  The report shall include:

     (1)  Information as to the number of syringe exchange participants served, the number of needles and syringes distributed, and the number of used needles and syringes collected;

     (2)  A demographic profile of the syringe exchange participants served, including but not limited to:  age, sex, ethnicity, area of residence, occupation, types of drugs used, length of drug use, and frequency of injection;

     (3)  Impact of the program on needle and syringe sharing and other high-risk behavior;

     (4)  Data on syringe exchange participants regarding human immunodeficiency virus (HIV) testing, counseling, drug treatment, and other social services, including referrals for HIV testing and counseling and for substance use disorder treatment;

     (5)  Impact on the transmission of HIV infection among injection drug users;

     (6)  Impact on behaviors that caused syringe exchange participants to be at risk for HIV transmission such as frequency of drug use and needle sharing;

     (7)  An assessment of the cost-effectiveness of the program versus direct and indirect costs of HIV infection; and

     (8)  Information on the percentage of persons served through treatment programs for injection drug users funded through the department that were attributed to needle exchange referrals.

     The report shall address the strengths and weaknesses of the program, the advisability of its continuation, amendments to the law, if appropriate, and other matters that may be helpful to the oversight committee in evaluating the program's efficacy. [L 1992, c 152, pt of §2; am L 2025, c 106, §5]